1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow Status Asthmaticus: new trials by email Literature Review of Status Asthmaticus trials Research Report on Status Asthmaticus
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized, Placebo/Active Crossover Dose-ranging Study for Safety and Efficacy in Asthma Patients. E004 (epinephrine inhalation aerosol), 90 mcg/actuation, E004 Placebo, E004 (epinephrine inhalation aerosol), 125 mcg - Asthma | Phase 1 / Phase 2 | Terminated | Amphastar Pharmaceuticals, Inc. | 9 | 2009-12-01 | 2018-05-16 |
Asthma (1) · Dyspnea (1) · Respiratory Sounds (1)
Bronchial Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Immune System Diseases (1) · Lung Diseases (1) · Lung Diseases, Obstructive (1) · Pathological Conditions, Signs and Symptoms (1) · Respiration Disorders (1) · Respiratory Hypersensitivity (1) · Respiratory Tract Diseases (1) · Signs and Symptoms (1) · Signs and Symptoms, Respiratory (1)
Epinephrine (1)
Amphastar Pharmaceuticals, Inc. (1)
United States (1)